Checkpoint Therapeutics Ratios and Metrics

Market cap in millions ISK. Fiscal year is January - December.

Millions ISK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Aug '25 Aug 8, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Market Capitalization	80,165	95,498	81,928	90,646	128,376	37,039	Upgrade
Market Cap Growth	4.51%	16.56%	-9.62%	-29.39%	246.59%	79.96%	Upgrade
Last Close Price	18.15	15.71	13.30	14.25	20.10	12.97	Upgrade
PE Ratio	21.86	11.73	20.39	18.56	11.96	15.77	Upgrade
PS Ratio	4.70	5.77	5.94	6.53	5.79	4.43	Upgrade
PB Ratio	1.19	1.07	1.00	1.12	1.64	1.93	Upgrade
P/FCF Ratio	-	-	-	-	15.77	-	Upgrade
P/OCF Ratio	-	-	-	-	15.46	-	Upgrade
Debt / Equity Ratio	1.02	0.68	0.86	0.91	0.73	1.99	Upgrade
Debt / FCF Ratio	-	-	-	-	7.04	-	Upgrade
Return on Equity (ROE)	5.16%	5.47%	2.83%	5.46%	21.86%	13.09%	Upgrade
Return on Assets (ROA)	1.12%	1.36%	0.73%	1.59%	5.77%	1.99%	Upgrade
Earnings Yield	11.41%	8.53%	4.91%	5.39%	8.36%	6.34%	Upgrade
FCF Yield	-27.03%	-2.58%	-43.75%	-37.70%	6.34%	-33.52%	Upgrade
Dividend Yield	27.55%	31.83%	-	2.81%	-	-	Upgrade
Payout Ratio	-	-	47.59%	-	-	-	Upgrade
Buyback Yield / Dilution	1.32%	1.26%	0.60%	-14.10%	-82.18%	-9.60%	Upgrade
Total Shareholder Return	28.87%	33.08%	0.60%	-11.29%	-82.18%	-9.60%	Upgrade

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.